KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Castle Biosciences (CSTL) over the last 4 years, with Q3 2025 value amounting to $202.0 million.

  • Castle Biosciences' Short-term Investments rose 929.2% to $202.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.0 million, marking a year-over-year increase of 929.2%. This contributed to the annual value of $173.4 million for FY2024, which is 2021.59% up from last year.
  • Per Castle Biosciences' latest filing, its Short-term Investments stood at $202.0 million for Q3 2025, which was up 929.2% from $193.7 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Short-term Investments registered a high of $202.0 million during Q3 2025, and its lowest value of $117.2 million during Q1 2023.
  • Its 4-year average for Short-term Investments is $159.0 million, with a median of $156.3 million in 2024.
  • As far as peak fluctuations go, Castle Biosciences' Short-term Investments surged by 510.46% in 2023, and later skyrocketed by 3431.35% in 2024.
  • Over the past 4 years, Castle Biosciences' Short-term Investments (Quarter) stood at $135.7 million in 2022, then increased by 6.32% to $144.3 million in 2023, then rose by 20.22% to $173.4 million in 2024, then grew by 16.48% to $202.0 million in 2025.
  • Its Short-term Investments stands at $202.0 million for Q3 2025, versus $193.7 million for Q2 2025 and $185.5 million for Q1 2025.